Community Pharmacy England (CPE) - News updates

Drug alert number: EL (25)A/04 Date issued: 30 January 2025 Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination. Amlodipine Bristol Lab 2.5 mg Tablets, PL 17907/0435 SNOMED Code: 38095611000001108 Batch Number Expiry Date Pack Size First Distributed MF23016 July 2025 28 29/9/2023 MF23017 [...] The post MHRA Class 2 Medicines Recall: Amlodipine Bristol Lab 2.5mg tablets (Bristol Laboratories Limited) appeared first on Community Pharmacy England.

Following discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (30/01/2025) announced the following list of price concessions for January 2025. Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health [...] The post January 2025 Price Concessions: 4th Update appeared first on Community Pharmacy England.

Yesterday, Community Pharmacy England joined with the British Dental Association, British Medical Association, Optometric Fees Negotiating Committee and the Association for Primary Care Audiology Providers, to host a ‘Future of Primary Care’ Parliamentary drop-in event. The event, sponsored by pharmacy APPG Chair, Steve Race MP, was well attended with 40 MPs and their staff present [...] The post CPE and primary care professions host joint parliamentary event appeared first on Community Pharmacy England.

Community pharmacies received strong backing yesterday in Parliament, with numerous Peers speaking out in support of the sector, recognising their vital role in community healthcare and raising the urgent funding challenges they face. Discussions in the House of Lords included expressing a desire to expand community pharmacies’ role in public health and the Government’s commitment [...] The post Peers highlight critical issues for community pharmacies in Parliament appeared first on Community Pharmacy England.

The Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution [...] The post Drug Tariff Watch – February 2025 appeared first on Community Pharmacy England.

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 6 January 2025) has been published and includes articles on: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation Letters and medicine recalls sent to healthcare professionals in December 2024 To see the latest [...] The post MHRA Drug Safety Update: January 2025 appeared first on Community Pharmacy England.

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Memantine (Valios®) 5mg orodispersible tablets sugar free MSN/2025/005 Tier 2 – medium impact Date of issue: 28th January 2025 Memantine (Valios®) 5mg orodispersible tablets sugar free are out of stock until late April 2025. Memantine (Valios®) 5 mg/10 mg/15 mg/20 mg [...] The post Medicine Supply Notification: Memantine (Valios® ) 5mg orodispersible tablets sugar free appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has entered into consultation with Community Pharmacy England (CPE) regarding the 2024/25 and 2025/26 funding contractual framework. The discussions will set the future direction for community pharmacy as it plays a vital role in supporting delivery of the reforms set out in the government’s Plan for Change. [...] The post Government opens discussions with Community Pharmacy England over 25/26 funding contract appeared first on Community Pharmacy England.

Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has agreed to retrospectively adjust the reimbursement price of Gaviscon Infant oral powder 15 dual dose sachets for EPS prescriptions dispensed between May 2023 to November 2024. The term ‘dual dose sachets’ was updated to [...] The post Retrospective reimbursement price adjustments for Gaviscon Infant oral powder sachets dual dose sachets appeared first on Community Pharmacy England.

Community pharmacies are reminded that Inclisiran (Leqvio®) 284mg/1.5ml solution for injection pre-filled syringe is available to order from the nominated wholesaler AAH UK at a nominal charge of £45 per pack for supply against NHS prescriptions, as agreed within the commercial agreement between Novartis Pharmaceuticals UK Ltd and NHS England. A summary of the current [...] The post Inclisiran (Leqvio®) orders for NHS prescriptions – check your invoices appeared first on Community Pharmacy England.